ACCESSION: MSBNK-SMB_Measured-HSA032P0177001
RECORD_TITLE: Annotated; Cotinine; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'RA19-pos_1281': {'bp': 4278.0, 'sum': 7729.0}, 'RA2-pos_1277': {'bp': 3028.0, 'sum': 7038.0}, 'RA15-pos_1265': {'bp': 3011.0, 'sum': 5914.0}, 'HC20-pos_1194': {'bp': 1947.0, 'sum': 5212.0}, 'HC25-pos_1134': {'bp': 1843.0, 'sum': 4525.0}, 'HC25-pos_1184': {'bp': 1526.0, 'sum': 3459.0}, 'RA21-pos_996': {'bp': 1243.0, 'sum': 3714.0}, 'HC17-pos_1135': {'bp': 1175.0, 'sum': 3051.0}, 'HC17-pos_1116': {'bp': 1118.0, 'sum': 3261.0}, 'RA25-pos_1138': {'bp': 1050.0, 'sum': 1999.0}, 'HC25-pos_1122': {'bp': 1027.0, 'sum': 2608.0}, 'HC21-pos_1115': {'bp': 742.0, 'sum': 2342.0}}
COMMENT: RETENTION_TIME_STDEV 0.022
COMMENT: PRECURSOR_M/Z_RAW 177.101451
COMMENT: PRECURSOR_M/Z_STDEV 0.000501
COMMENT: PRECURSOR_IN_MS1 mz 177.102011; int 239.545; delta(ppm) 8.381462
COMMENT: PROPOSED_CHARGE_STATE +1; mz 178.104920; int 24.390; cor 0.733
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 10.710; C8H17O2P; [M+H]+; delta(ppm) -10.710145
COMMENT: PROPOSED_MF SevenGoldenRules 1.329; C10H12N2O; [M+H]+; delta(ppm) -1.328830
COMMENT: PROPOSED_MF MS-FINDER 4.520; C10H12N2O; [M+H]+; delta(ppm) -1.323820
COMMENT: PROPOSED_MF MS-FINDER 2.529; C8H17O2P; [M+H]+; delta(ppm) -10.650349
COMMENT: PROPOSED_MF SIRIUS5_Sirius 23.955; C10H12N2O; [M+H]+; delta(ppm) -1.323820
COMMENT: PROPOSED_MF SIRIUS5_Sirius 21.015; C7H13FN2O2; [M+H]+; delta(ppm) -7.775715
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.555; C8H17O2P; [M+H]+; delta(ppm) -10.650349
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.990; C10H12N2O; [M+H]+; delta(ppm) -1.323820
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.010; C7H13FN2O2; [M+H]+; delta(ppm) -7.775715
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.929; C10H12N2O; [M+H]+; delta(ppm) -1.323820
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.810; C7H13FN2O2; [M+H]+; delta(ppm) -7.775715
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.346; C5H11FN5O; [M+H]+; delta(ppm) -0.194474
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.984; C8H10N5; [M+H]+; delta(ppm) 6.257518
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.609; C6H15N3OP; [M+H]+; delta(ppm) -3.069152
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.988; C7H15ClN3; [M+H]+; delta(ppm) -119345.581727
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.112; C4H13N6P; [M+H]+; delta(ppm) 4.512160
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.555; C8H17O2P; [M+H]+; delta(ppm) -10.650349
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.970; C10H12N2O; [M+H]+; delta(ppm) -1.323820
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.030; C7H13FN2O2; [M+H]+; delta(ppm) -7.775715
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 23.000; UIKROCXWUNQSPJ-VIFPVBQESA-N; C10H12N2O; Massbank:LU051104 Cotinine(5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; UIKROCXWUNQSPJ-UHFFFAOYSA-N; C10H12N2O; COTININE
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.911; VQAMXXXBDNKODW-UHFFFAOYSA-N; [M+H]+; O=C1NN(C=2C=CC=CC2C)CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.879; RSNDUSNTDLGWQM-UHFFFAOYSA-N; [M+H]+; OC=1C=CC=2N=C(N(C2C1)CC)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.868; YDWIHMVUUGVOLZ-UHFFFAOYSA-N; [M+H]+; O=C(NN1C=2C=CC=CC2CC1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.758; SVJPLZNMCJQWPJ-UHFFFAOYSA-N; [M+H]+; O=C1NN(C2=CC=C(C=C2)C)CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.743; UIKROCXWUNQSPJ-UHFFFAOYNA-N; [M+H]+; CN1C(CCC1=O)C1=CN=CC=C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.607; UIKROCXWUNQSPJ-UHFFFAOYNA-N; [M+H]+; Cotinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.693; GQLSEYOOXBRDFZ-UEQNJFAPNA-N; [M+H]+; UNPD113047
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.490; CXOGMMQKRNROKJ-UHFFFAOYSA-N; [M+H]+; Cyfusine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.407; QZAYGJVTTNCVMB-UHFFFAOYSA-N; [M+H]+; Serotonin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.335; NUJFYQDHTBBYKQ-JLDDOWRYNA-N; [M+H]+; UNPD92821
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.223; SNIXRMIHFOIVBB-UHFFFAOYSA-N; [M+H]+; N-hydroxy tryptamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.128; CPWSAKUPXWXJPQ-MDOHGIEYNA-N; [M+H]+; UNPD61396
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.048; YJXZYKIERAACAC-UHFFFAOYSA-N; [M+H]+; 4-(hydroxyimino)-3,6,6-trimethylbicyclo[3.1.0]hex-2-ene-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.963; LJQBMYDFWFGESC-UHFFFAOYSA-N; [M+H]+; 4-Methylaminorex
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.962; BXJMRXBQNLKDCI-UHFFFAOYSA-N; [M+H]+; 2,2-Dimethyl-1,2-Dihydroquinazolin-4(3H)-One
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.942; BWVQIBKUGHYXLO-UHFFFAOYSA-N; [M+H]+; 1-(3-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.942; SVJPLZNMCJQWPJ-UHFFFAOYSA-N; [M+H]+; 1-(4-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.938; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; 2-Propen-1-one, 3-(dimethylamino)-1-(3-pyridinyl)-
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.842; ILNUQOOAYAAWSD-UHFFFAOYSA-N; [M+H]+; 1-methyl-2(h)-quinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.819; RSNDUSNTDLGWQM-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methyl-1H-1,3-benzodiazol-6-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.800; RSEAKKXLVFFQGA-UHFFFAOYSA-N; [M+H]+; 5,6-diethyl-[1,3]oxazolo[5,4-b]pyridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.749; YDWIHMVUUGVOLZ-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-indol-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.746; GAHLHXRCZDVQSW-UHFFFAOYSA-N; [M+H]+; 1-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.730; VQAMXXXBDNKODW-UHFFFAOYSA-N; [M+H]+; 1-(2-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.727; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; 4-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.720; UUSVBSIMANJSGD-UHFFFAOYSA-N; [M+H]+; 9-hydroxy-2,4-dimethyl-octahydro-2H-1??-pyrido[1,2-a]pyrimidin-5-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.715; SZDFIVJGWVHZAV-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.687; OFCNTYBPPAQCRE-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-3H-indol-5-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.678; WZTKTNRVJAMKAS-UHFFFAOYSA-N; [M+H]+; UNPD48906
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.575; WNWJSYYPDDQIQV-UEQNJFAPNA-N; [M+H]+; (1S)-1-amino-2-(1H-indol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.380; CLUOVKPXNPEBBU-UHFFFAOYSA-N; [M+H]+; N'-phenylbut-2-enehydrazide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.106; PKUTWSKGCIVVON-UHFFFAOYSA-N; [M+H]+; 1-ethoxy-3-methyl-1??-phosphinan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PKUTWSKGCIVVON-UHFFFAOYSA-N; [M+H]+; 1-ethoxy-3-methyl-1??-phosphinan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UIKROCXWUNQSPJ-UHFFFAOYNA-N; [M+H]+; Cotinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.938; GQLSEYOOXBRDFZ-UEQNJFAPNA-N; [M+H]+; UNPD113047
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.926; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; 2-Propen-1-one, 3-(dimethylamino)-1-(3-pyridinyl)-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.706; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; 4-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.698; GAHLHXRCZDVQSW-UHFFFAOYSA-N; [M+H]+; 1-methoxy-3-(aminomethyl)indole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.691; SZDFIVJGWVHZAV-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-2,3-dihydro-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.686; YJXZYKIERAACAC-UHFFFAOYSA-N; [M+H]+; 4-(hydroxyimino)-3,6,6-trimethylbicyclo[3.1.0]hex-2-ene-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.681; QZAYGJVTTNCVMB-UHFFFAOYSA-N; [M+H]+; Serotonin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.681; WZTKTNRVJAMKAS-UHFFFAOYSA-N; [M+H]+; UNPD48906
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.676; UUSVBSIMANJSGD-UHFFFAOYSA-N; [M+H]+; 9-hydroxy-2,4-dimethyl-octahydro-2H-1??-pyrido[1,2-a]pyrimidin-5-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.665; CPWSAKUPXWXJPQ-MDOHGIEYNA-N; [M+H]+; UNPD61396
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.663; CXOGMMQKRNROKJ-UHFFFAOYSA-N; [M+H]+; Cyfusine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.650; NUJFYQDHTBBYKQ-JLDDOWRYNA-N; [M+H]+; UNPD92821
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.649; BXJMRXBQNLKDCI-UHFFFAOYSA-N; [M+H]+; 2,2-Dimethyl-1,2-Dihydroquinazolin-4(3H)-One
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.641; LJQBMYDFWFGESC-UHFFFAOYSA-N; [M+H]+; 4-Methylaminorex
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.636; BWVQIBKUGHYXLO-UHFFFAOYSA-N; [M+H]+; 1-(3-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.636; SVJPLZNMCJQWPJ-UHFFFAOYSA-N; [M+H]+; 1-(4-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.636; VQAMXXXBDNKODW-UHFFFAOYSA-N; [M+H]+; 1-(2-methylphenyl)pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.622; WNWJSYYPDDQIQV-UEQNJFAPNA-N; [M+H]+; (1S)-1-amino-2-(1H-indol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.615; ILNUQOOAYAAWSD-UHFFFAOYSA-N; [M+H]+; 1-methyl-2(h)-quinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.612; RSEAKKXLVFFQGA-UHFFFAOYSA-N; [M+H]+; 5,6-diethyl-[1,3]oxazolo[5,4-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.610; RSNDUSNTDLGWQM-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methyl-1H-1,3-benzodiazol-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.597; SNIXRMIHFOIVBB-UHFFFAOYSA-N; [M+H]+; N-hydroxy tryptamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.561; OFCNTYBPPAQCRE-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-3H-indol-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.479; YDWIHMVUUGVOLZ-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-indol-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.301; CLUOVKPXNPEBBU-UHFFFAOYSA-N; [M+H]+; N'-phenylbut-2-enehydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.570; QZAYGJVTTNCVMB-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indol-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.115; UIKROCXWUNQSPJ-VIFPVBQESA-N; [M+H]+; (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.198; LJQBMYDFWFGESC-UHFFFAOYSA-N; [M+H]+; 4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; MAXMUBIIZUKOJF-UHFFFAOYSA-N; [M+H]+; 1-pyridin-4-ylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; CSNJUQMJDHNKHI-UHFFFAOYSA-N; [M+H]+; 1-pyridin-2-ylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; GQLSEYOOXBRDFZ-UHFFFAOYSA-N; [M+H]+; 2-pyridin-3-ylpyrrolidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; KYLMCPQKMNYJGT-UHFFFAOYSA-N; [M+H]+; 3,3-dimethyl-4-pyridin-4-ylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; RIKQERCQCNJIIU-UHFFFAOYSA-N; [M+H]+; 6-pyridin-2-ylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; MZLRFUCMBQWLNV-UHFFFAOYSA-N; [M+H]+; 3-(dimethylamino)-1-pyridin-3-ylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; FKIRTWDHOWAQGX-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; BWERGHWJEBQNQV-SOFGYWHQSA-N; [M+H]+; (E)-3-(dimethylamino)-1-pyridin-2-ylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; JZGHSXBVKSMAKH-VMPITWQZSA-N; [M+H]+; (E)-3-(dimethylamino)-1-pyridin-4-ylprop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; GGPHOOFWHDUFIG-XYOKQWHBSA-N; [M+H]+; (E)-N-but-3-en-2-yloxy-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; ZANPCQHDEUORJP-UHFFFAOYSA-N; [M+H]+; 4,4-dimethyl-2-pyridin-2-yl-5H-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; NXPTYENGRYHQBC-KPKJPENVSA-N; [M+H]+; (E)-N-(2-methylprop-2-enoxy)-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; SNIXRMIHFOIVBB-UHFFFAOYSA-N; [M+H]+; N-[2-(1H-indol-3-yl)ethyl]hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.928; YKDYCKHEKOEVJM-UHFFFAOYSA-N; [M+H]+; (4-methoxy-1H-indol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; SZDFIVJGWVHZAV-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1,3-dihydroindol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; AVLYOUOURMHIHZ-UHFFFAOYSA-N; [M+H]+; 2-[4-(2-aminoethoxy)phenyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; BBPWQLMHOSRDMA-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,2,3,5-tetrahydro-1,5-benzodiazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; TZPIKGCQLFRHGR-UHFFFAOYSA-N; [M+H]+; 4-amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; CLKQZOVQZNETMH-UHFFFAOYSA-N; [M+H]+; 3-amino-1-phenylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.880; MJPWQUIXUPCRAW-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-indol-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; ATJDZCZAGYKBTH-UHFFFAOYSA-N; [M+H]+; 7-(aminomethyl)-3,4-dihydro-2H-isoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; ZZEYCGJAYIHIAZ-UHFFFAOYSA-N; [M+H]+; 4-methyl-1-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; JXFJQPDXISQZHE-UHFFFAOYSA-N; [M+H]+; N-(2,3-dihydro-1H-isoindol-5-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; SOTNTWXGJKWKIM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1-methyl-3H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; RFAJSRJOKXNYCH-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-2-methyl-3H-isoindol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; JQKHEKMMKSMRTE-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-7,8-dihydro-6H-quinolin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; UDKJUMSGHZGQEH-UHFFFAOYSA-N; [M+H]+; 4-amino-1-phenylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; UMDWJYHTZUWTET-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1H-indol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; PYVVLSILSIVNQC-UHFFFAOYSA-N; [M+H]+; 5-amino-1-ethyl-3H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; RHINWRKJVGGOJR-UHFFFAOYSA-N; [M+H]+; 2-amino-N-prop-2-enylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; LOZKZWIQDVEDCQ-UHFFFAOYSA-N; [M+H]+; 1-(6-amino-2,3-dihydroindol-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; BAUHDHWVXAOSEF-VIFPVBQESA-N; [M+H]+; (2S)-N-methyl-2,3-dihydro-1H-indole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; WSDUFDGEYKOQRT-UHFFFAOYSA-N; [M+H]+; 1-(5-amino-2,3-dihydroindol-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; YNFLIDHXMNKSQR-UHFFFAOYSA-N; [M+H]+; 3-propyl-1H-benzimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; ZJMZHOMUFKQBLT-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-3,4-dihydro-1H-quinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.821; ZFSYJCQFOKJSFE-UHFFFAOYSA-N; [M+H]+; 1-(7-amino-2,3-dihydroindol-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; XCWLYFPMRHWWAG-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)-2-methyl-3H-isoindol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; ULWJTPAOSJSHFG-UHFFFAOYSA-N; [M+H]+; 6-amino-1-methyl-3,4-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; LRIVVMZEHDTDGA-UHFFFAOYSA-N; [M+H]+; 7-amino-2-methyl-3,4-dihydroisoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; FWPPPTIFLPLVOD-UHFFFAOYSA-N; [M+H]+; 6-amino-2-methyl-3,4-dihydroisoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; KZGROFOZYOFEFZ-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-3,4-dihydroisoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.812; PSDSAEYHBZOZBR-UHFFFAOYSA-N; [M+H]+; 6-amino-2-ethyl-3H-isoindol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; AHNRHYLMLVGCOC-UHFFFAOYSA-N; [M+H]+; 5-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; LAULYXTUHMXWOU-UHFFFAOYSA-N; [M+H]+; 5-(3-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; IOMOVAPYJQVJDK-UHFFFAOYSA-N; [M+H]+; 1-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; HXNWGBPRRHESCL-UHFFFAOYSA-N; [M+H]+; 1-(1-methylbenzimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; ZQGGRBIDRBYUJS-UHFFFAOYSA-N; [M+H]+; 1-(3-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; OFWIPSFSNBNOQC-UHFFFAOYSA-N; [M+H]+; 1-(2-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; YMXKVIDETJRFHD-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-3,4-dihydro-2H-isoquinolin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; IWHJGOLLYAXMLD-UHFFFAOYSA-N; [M+H]+; 5-methyl-2,3-dihydro-1H-1,5-benzodiazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; PLQUEAJMHWMBTG-UHFFFAOYSA-N; [M+H]+; 2-(2-methyl-4,5,6,7-tetrahydro-1,3-benzoxazol-4-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; LWGKCPAYDQWMMS-UHFFFAOYSA-N; [M+H]+; 5-(1-methyl-2,3-dihydropyrrol-5-yl)-1H-pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; OOBQTKJLWXKQHA-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)-3,4-dihydro-1H-quinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; VGOSHSFVBSXTOZ-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; YIOYWZUOBVMFGA-UHFFFAOYSA-N; [M+H]+; 1-(5-amino-1,3-dihydroisoindol-2-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; WZTKTNRVJAMKAS-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indol-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; RETCYVKOCFWWTL-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1H-indol-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; YZYJYCPYUXPNPE-UHFFFAOYSA-N; [M+H]+; 3-amino-1-methyl-3,4-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; IWARVYFPBLDOAK-UHFFFAOYSA-N; [M+H]+; 6-amino-3,3-dimethyl-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; KHWGWQQVNONIPZ-UHFFFAOYSA-N; [M+H]+; 4-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; QYJOWWRUCCAUHW-UHFFFAOYSA-N; [M+H]+; 5-amino-3,3-dimethyl-1H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; YATNLYZMTPNWHI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1,4-dihydroisoquinolin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; NSAVOLZYPAFSLW-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,2,3,5-tetrahydro-1,5-benzodiazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; JZMHFZCLNHTHSO-UHFFFAOYSA-N; [M+H]+; 2-[3-(cyanomethyl)-7-oxabicyclo[2.2.1]heptan-2-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; JNZGAKJBZUGXCU-UHFFFAOYSA-N; [M+H]+; 1-methyl-5-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; SBBGNRXYCGCZGA-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,3,4,5-tetrahydro-1,4-benzodiazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; YGCVNEQVUUMKJL-UHFFFAOYSA-N; [M+H]+; 2-amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; XTQFXSVIFJUEAP-UHFFFAOYSA-N; [M+H]+; 3-amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; CAPDPGRIQUJAGR-UHFFFAOYSA-N; [M+H]+; N-(3-aminophenyl)cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; QEZZUFANNFFZIH-UHFFFAOYSA-N; [M+H]+; 7-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; YLPNAIOOSLKUHD-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline-6-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; XRJMPABWIZHNQA-UHFFFAOYSA-N; [M+H]+; 8-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; SWXSODIZVQALAJ-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; DPCGMMLZFLMVGJ-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline-7-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; GTNSBFKKRPRPKU-UHFFFAOYSA-N; [M+H]+; 8-amino-2,3,4,5-tetrahydro-2-benzazepin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; YWUNGYFXNDOGNZ-UHFFFAOYSA-N; [M+H]+; 1-phenylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.776; RXAVXDBLOBNIFT-UHFFFAOYSA-N; [M+H]+; 4,4-dimethyl-3,1-benzoxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; ZJZASJONSHRXQE-UHFFFAOYSA-N; [M+H]+; 3-amino-5-ethyl-1,3-dihydroindol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; JFMNKDRNEZZRBW-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.769; MIHVXRGWIJOXCB-UHFFFAOYSA-N; [M+H]+; 3-amino-1,5-dimethyl-3H-indol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; WKFFHKBGGZHQAX-UHFFFAOYSA-N; [M+H]+; 3-phenylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; OFBPSKIFXNJCAG-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; FIARATPVIIDWJT-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; NBOQPHDHUGMWDD-UHFFFAOYSA-N; [M+H]+; 2-(2-methyl-1,3-benzoxazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; CWVWILIKKMHQDN-XYOKQWHBSA-N; [M+H]+; (E)-1-(3-methylpyridin-4-yl)-N-prop-2-enoxymethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; MQMWEVBWFGVBBL-DHZHZOJOSA-N; [M+H]+; (E)-1-(6-methylpyridin-2-yl)-N-prop-2-enoxymethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.762; CQFSGSFSOWEIGO-UHFFFAOYSA-N; [M+H]+; 3-(1H-benzimidazol-2-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.761; RDKNTOVJVFYGPA-UHFFFAOYSA-N; [M+H]+; 3,3-dimethyl-1,4-dihydroquinoxalin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.759; PRGOOZYYBRKHKN-UHFFFAOYSA-N; [M+H]+; 2-butan-2-yloxypyridine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.758; CQWMZWLOIWMFOA-UHFFFAOYSA-N; [M+H]+; 5-(1-aminoethyl)-1,3-dihydroindol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.756; QUESAGUERRSXJX-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-phenylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; FDRHNNNJJNRFLO-UHFFFAOYSA-N; [M+H]+; 1-(2-methyl-1,3-benzoxazol-6-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; AUAKXRGQXZRTQC-UHFFFAOYSA-N; [M+H]+; 3-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.745; RMZGIXQVAQTNNP-UHFFFAOYSA-N; [M+H]+; 5-phenylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; PINRUEQFGKWBTO-UHFFFAOYSA-N; [M+H]+; 3-methyl-5-phenyl-1,3-oxazolidin-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; GPSGRRNYZJYVQT-UHFFFAOYSA-N; [M+H]+; 4-methyl-4-phenylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -4.394; UIKROCXWUNQSPJ; [M+H]+; Cotinina
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.972; DOHZNHZHDHMXQB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.073; GQLSEYOOXBRDFZ; [M+H]+; N-Formylnornicotine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.678; WHAUNCLSZCNCTE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.758; IOMOVAPYJQVJDK; [M+H]+; (4-Aminophenyl)pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.024; JNZGAKJBZUGXCU; [M+H]+; 1-Methyl-5-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.317; ZQGGRBIDRBYUJS; [M+H]+; Oprea1_818804
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.876; SNIXRMIHFOIVBB; [M+H]+; N-hydroxyl-tryptamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.783; SZDFIVJGWVHZAV; [M+H]+; 3-(2-aminoethyl)indolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.391; OFWIPSFSNBNOQC; [M+H]+; 1-(2-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.083; XRJMPABWIZHNQA; [M+H]+; 8-amino-1,3,4,5-tetrahydro-1-benzazepin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.137; SSEYDGGXERWOIC; [M+H]+; Acetone benzoylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.509; ZJMZHOMUFKQBLT; [M+H]+; 4-(aminomethyl)-1,2,3,4-tetrahydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.423; ULWJTPAOSJSHFG; [M+H]+; 6-amino-1-methyl-3,4-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.092; GGPHOOFWHDUFIG; [M+H]+; N-but-3-en-2-yloxy-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.218; LVPLGMIOSVEITG; [M+H]+; Oprea1_270461
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.490; MZLRFUCMBQWLNV; [M+H]+; dimethylaminopyridinylpropenone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -334.830; LWGKCPAYDQWMMS; [M+H]+; 6-Hydroxy-N-methyl Myosmine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.441; CAPDPGRIQUJAGR; [M+H]+; N-(3-aminophenyl)cyclopropylcarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.031; TZPIKGCQLFRHGR; [M+H]+; 4-Amino-N-cyclopropylbenzamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.737; QZAYGJVTTNCVMB; [M+H]+; Antemoqua
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.114; YKDYCKHEKOEVJM; [M+H]+; 4-Methoxyindole-3-methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.968; WNWJSYYPDDQIQV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -342.665; GAHLHXRCZDVQSW; [M+H]+; 1H-Indole-3-methanamine, 1-methoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -345.217; CQFSGSFSOWEIGO; [M+H]+; zlchem 37
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.298; CPWSAKUPXWXJPQ; [M+H]+; (7R)-7-methyl-6,7-dihydro-5H-cyclopenta[c]pyridine-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.486; NXPTYENGRYHQBC; [M+H]+; N-(2-methylprop-2-enoxy)-1-pyridin-4-ylmethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.837; MOBYIROICQZPDG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -349.571; GAVZUXBKQVMADB; [M+H]+; 1-cyclopropyl-3-phenylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.672; BBPWQLMHOSRDMA; [M+H]+; Oprea1_799819
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -354.120; WZTKTNRVJAMKAS; [M+H]+; 6-Hydroxytryptamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -354.474; FKIRTWDHOWAQGX; [M+H]+; 3-(2-aminoethyl)-1H-indol-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.675; XVTZMKHBKGYOKU; [M+H]+; 3-(1,4,5,6-tetrahydropyrimidin-2-yl)phenol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.770; HXNWGBPRRHESCL; [M+H]+; 2-Benzimidazolemethanol,1-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -361.688; MLSKUXJIZZNRSU; [M+H]+; N-allyl-N''-phenylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.771; ASEAXFLYJBVEGB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.819; UGMMLOHVKZGOJU; [M+H]+; ACMC-20crwz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -363.956; CLUOVKPXNPEBBU; [M+H]+; N''-phenylbut-2-enehydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -365.904; DKWUEAZDXGFDFD; [M+H]+; N-(dimethylaminomethylidene)benzamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -366.918; OEGCCJDCPVXFLC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -368.132; HUHADASXDUCZMY; [M+H]+; 3-(Phenylhydrazono)-2-butanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.625; FDRHNNNJJNRFLO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.346; VQAMXXXBDNKODW; [M+H]+; Oprea1_493326
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -375.503; GPSGRRNYZJYVQT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -376.925; FFFAXGTZBUMKTI; [M+H]+; 6-(pyrrolidin-1-yl)nicotinaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.825; OIGIQMJAAZXDQH; [M+H]+; 1,4,5,6-Tetrahydro-5-phenoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -381.520; MQMWEVBWFGVBBL; [M+H]+; 1-(6-methylpyridin-2-yl)-N-prop-2-enoxymethanimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.116; BWVQIBKUGHYXLO; [M+H]+; 3-Pyrazolidinone, 1-(3-methylphenyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -384.023; SVJPLZNMCJQWPJ; [M+H]+; Oprea1_250793
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -387.561; XHYBFCBDMIPDON; [M+H]+; 1-phenyldiazinan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -387.995; OTXOLASULYVVKB; [M+H]+; N''-(4-methylbenzylidene)acetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -395.838; BGKOOWIPOZKILG; [M+H]+; alpha-Hydroxymethyltolazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -395.886; NUJFYQDHTBBYKQ; [M+H]+; 1,5-dimethyl-2,4-dihydro-1H-2,7-naphthyridin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -399.359; RDKNTOVJVFYGPA; [M+H]+; Oprea1_274771
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -399.404; RSNDUSNTDLGWQM; [M+H]+; 3-ethyl-2-methylbenzimidazol-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.185; TXONMTHZPYUUSK; [M+H]+; 1-(2-imidazolin-2-yl)-2-methoxybenzene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.623; VJWNLHRQOCVMNI; [M+H]+; 2-Propoxybenzimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -401.532; FIARATPVIIDWJT; [M+H]+; 5-methyl-1-phenylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -403.940; RSEAKKXLVFFQGA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -404.333; CVQPWOAQBMGTLS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -405.104; NLTYZPBQHXXZGL; [M+H]+; (5,6-dimethylbenzimidazol-2-yl)methan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -406.872; QLOGFFCTOGPFIU; [M+H]+; 2-(o-Toluidino)-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -408.473; GQRGMRVSJVMBMH; [M+H]+; 6-(tert-Butyl)-2-hydroxynicotinonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -413.048; DBCGDMLNSRGMLI; [M+H]+; 2-Benzylamino-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -419.202; BXJMRXBQNLKDCI; [M+H]+; Oprea1_263737
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.393; BWERGHWJEBQNQV; [M+H]+; ACMC-20aniv
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.772; YDWIHMVUUGVOLZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -422.880; MKENSKQNBRWBOI; [M+H]+; 2-(m-Toluidino)-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -425.049; LOZKZWIQDVEDCQ; [M+H]+; Oprea1_552062
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -427.308; LJQBMYDFWFGESC; [M+H]+; 4-Methylaminorex
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -427.655; LPMXHTSWSHVNSG; [M+H]+; 2-(methylamino)-1,4-dihydroisoquinolin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -429.422; WSDUFDGEYKOQRT; [M+H]+; Oprea1_842763
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -435.195; ZFSYJCQFOKJSFE; [M+H]+; Oprea1_302168
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -435.696; PGTOGOCRLGQJNM; [M+H]+; 1-(3-methylphenyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -438.136; PINRUEQFGKWBTO; [M+H]+; 2-Imino-3-methyl-5-phenyloxazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -439.956; PFCNDSQZKWGKTN; [M+H]+; (5,6-dimethylbenzimidazol-1-yl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -447.353; PMBQYJGSKZZJKC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -456.033; JZMHFZCLNHTHSO; [M+H]+; 7-Oxabicyclo(2.2.1)heptane-2,3-diacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -457.352; CXOGMMQKRNROKJ; [M+H]+; 1,2,3,3a,4,9b-hexahydropyrrolo[3,4-a]indolizin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -462.645; YWUNGYFXNDOGNZ; [M+H]+; Piperazinone, 1-phenyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -466.147; ZZEYCGJAYIHIAZ; [M+H]+; Phenidone B
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -467.447; YJXZYKIERAACAC; [M+H]+; Ambcb5621190
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -473.384; KIQXCFBLXGRXPY; [M+H]+; 2-(Fluoromethyl)dehydroornithine methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -484.267; YIOYWZUOBVMFGA; [M+H]+; 1-(5-amino-1,3-dihydroisoindol-2-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -484.499; RXAVXDBLOBNIFT; [M+H]+; 4,4-dimethyl-3,1-benzoxazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.990; UIKROCXWUNQSPJ; [M+H]+; Cotinina
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -15.030; UIKROCXWUNQSPJ; [M+H]+; Cotinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -149.879; GQLSEYOOXBRDFZ; [M+H]+; 2-(pyridin-3-yl)pyrrolidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -198.314; DOHZNHZHDHMXQB; [M+H]+; 1-Methyl-5-pyridin-3-ylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.907; LWGKCPAYDQWMMS; [M+H]+; 6-Hydroxy-N-Methylmyosmine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.371; AHNRHYLMLVGCOC; [M+H]+; (5S)-5-(4-aminophenyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.565; GGPHOOFWHDUFIG; [M+H]+; 4-Pyridinecarboxaldehyde, O-(1-methyl-2-propenyl)oxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.062; NXPTYENGRYHQBC; [M+H]+; 4-Pyridinecarboxaldehyde, O-(2-methyl-2-propenyl)oxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.575; WHAUNCLSZCNCTE; [M+H]+; (3E)-4-(methylamino)-1-(pyridin-3-yl)but-3-en-1-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -240.102; KIQXCFBLXGRXPY; [M+H]+; 3-Pentenoic acid, 2,5-diamino-2-(fluoromethyl)-, methyl ester, (E)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -247.817; MQMWEVBWFGVBBL; [M+H]+; 6-Methyl-2-pyridinecarboxaldehyde O-2-propenyloxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.974; UIKROCXWUNQSPJ; [M+H]+; Cotinine
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Cotinine, UIKROCXWUNQSPJ-VIFPVBQESA-N; Matching to 23 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0001046;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H12N2O
CH$EXACT_MASS: 176.094963
CH$SMILES: CN1[C@@H](CCC1=O)C2=CN=CC=C2
CH$IUPAC: InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3/t9-/m0/s1
CH$NAME: Cotinine
CH$NAME: Cotinine
CH$NAME: (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
CH$LINK: INCHIKEY UIKROCXWUNQSPJ-VIFPVBQESA-N
CH$LINK: PUBCHEM CID:854019
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.897
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 177.102005
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-9200000000-68e4ac53c845c4b04607
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0647625 66.9646 70.064913 8.8061 39.32 0.4421 12 f{C4H8N1}/-5.18ppm,p-C6H5N1O1
  72.9372364 47.3948 72.937397 8.5553 30.56 0.1648 11 ?
  80.0495363 999.0000 80.049726 6.2336 0.00 0.8741 12 f{C5H6N1}/0.76ppm,p-C5H7N1O1
  91.0542687 33.1072 91.054507 15.8038 22.58 0.4521 10 f{C7H7}/0.46ppm,p-C3H6N2O1
  98.0600528 362.0401 98.060325 5.4558 146.63 0.7832 12 f{C5H8N1O1}/0.13ppm,p-C5H5N1
  118.0664551 43.9599 118.066836 11.1717 14.62 0.7048 11 f{C8H8N1}/11.26ppm,p-C2H5N1O1
  120.0804376 43.2496 120.080831 13.8324 12.91 0.6685 11 f{C8H10N1}/-2.82ppm,p-C2H3N1O1
  146.0604439 60.3045 146.061008 10.3245 25.72 0.8258 12 f{C9H8N1O1}/2.76ppm,p-C1H5N1
  149.0700405 21.4150 149.070627 9.3446 8.50 0.7849 9 f{C8H9N2O1}/-6.03ppm,p-C2H4
  177.1027827 216.3208 177.103708 7.4138 77.72 1.0000 12 f{C10H13N2O1}/3.07ppm,p
PK$NUM_PEAK: 10
PK$PEAK: m/z int. rel.int.
  70.064762 66.96 66
  72.937236 47.39 47
  80.049536 999.00 999
  91.054269 33.11 33
  98.060053 362.04 362
  118.066455 43.96 43
  120.080438 43.25 43
  146.060444 60.30 60
  149.070041 21.41 21
  177.102783 216.32 216
//
